CompareMarketResearchRequest a sample
Home / Healthcare / Enzyme Linked Immunosorbent Assay

Healthcare · Market report

Enzyme Linked Immunosorbent Assay Market Size, Share and Forecast 2026-2036

The global enzyme linked immunosorbent assay market is worth USD 3.1 bn in 2026 and is forecast to reach USD 5.1 bn by 2036, growing at a 5.2% CAGR. United States is the largest country market and Assay kits is the largest by product segment.

USD 3.1 bnMarket size 2026
USD 5.1 bnForecast 2036
5.2%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global enzyme linked immunosorbent assay market is worth USD 3.1 bn in 2026 and is forecast to reach USD 5.1 bn by 2036, growing at a 5.2% CAGR. United States is the largest country market and Assay kits is the largest by product segment.

ScopeEnzyme-linked immunosorbent assay kits, reagents and plates used for diagnostics, research, and food and environmental testing.
IndustryHealthcare
Value 2025USD 2.9 bn
Value 2026USD 3.1 bn
Value 2036USD 5.1 bn
CAGR 2026-20365.2%
Volume 20261,260 million tests
Volume 20361,990 million tests
Average price 2026USD 2.43 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Enzyme Linked Immunosorbent Assay market size and forecast, 2026-2036

Exhibit 1The global enzyme linked immunosorbent assay market is forecast to grow from USD 3.1 bn in 2026 to USD 5.1 bn by 2036, a rise of 66%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 5.2%
Enzyme Linked Immunosorbent Assay market value, 2025 to 2036Market value by year. 2025: USD 2.9 bn; 2026: USD 3.1 bn; 2027: USD 3.2 bn; 2028: USD 3.4 bn; 2029: USD 3.6 bn; 2030: USD 3.7 bn; 2031: USD 3.9 bn; 2032: USD 4.1 bn; 2033: USD 4.4 bn; 2034: USD 4.6 bn; 2035: USD 4.8 bn; 2036: USD 5.1 bn. Compound annual growth rate 2026 to 2036: 5.2%.20253.1 bn20263.9 bn20315.1 bn20365.2% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 3.1 bn
2027USD 3.2 bn
2028USD 3.4 bn
2029USD 3.6 bn
2030USD 3.7 bn
2031USD 3.9 bn
2032USD 4.1 bn
2033USD 4.4 bn
2034USD 4.6 bn
2035USD 4.8 bn
2036USD 5.1 bn

Enzyme Linked Immunosorbent Assay market segmentation

By product

Exhibit 2Assay kits is the largest segment by product, with 62.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Enzyme Linked Immunosorbent Assay market share by product, 2026Share of 2026 revenue by product. Assay kits: 62.0%; Reagents and consumables: 26.0%; Instruments and readers: 12.0%.Assay kits62.0%Reagents and consumables26.0%Instruments and readers12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Assay kits62.0%63.9%USD 1.9 bn5.5%
Reagents and consumables26.0%24.3%USD 795 mn4.5%
Instruments and readers12.0%11.8%USD 367 mn5.0%

By application

Exhibit 3Infectious disease diagnostics adds the most revenue by application, growing from USD 1.0 bn in 2026 to USD 1.7 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Enzyme Linked Immunosorbent Assay market by application, 2026 and 2036Revenue by application in 2026 and 2036. Infectious disease diagnostics: USD 1.0 bn in 2026, USD 1.7 bn in 2036, change +59%; Research and biopharma: USD 673 mn in 2026, USD 1.1 bn in 2036, change +67%; Autoimmune and allergy testing: USD 490 mn in 2026, USD 855 mn in 2036, change +75%; Oncology and endocrinology: USD 428 mn in 2026, USD 735 mn in 2036, change +71%; Food and environmental: USD 428 mn in 2026, USD 714 mn in 2036, change +67%.20262036 forecastChangeInfectious disease diagnostics+59%1.0 bn1.7 bnResearch and biopharma+67%673 mn1.1 bnAutoimmune and allergy testing+75%490 mn855 mnOncology and endocrinology+71%428 mn735 mnFood and environmental+67%428 mn714 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Infectious disease diagnostics34.0%32.6%USD 1.0 bn4.7%
Autoimmune and allergy testing16.0%16.8%USD 490 mn5.7%
Oncology and endocrinology14.0%14.5%USD 428 mn5.5%
Research and biopharma22.0%22.1%USD 673 mn5.2%
Food and environmental14.0%14.1%USD 428 mn5.2%

By assay format

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Sandwich44.0%43.0%USD 1.3 bn5.0%
Direct14.0%13.0%USD 428 mn4.4%
Indirect22.0%22.0%USD 673 mn5.2%
Competitive20.0%22.0%USD 612 mn6.2%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Diagnostic laboratories34.0%33.0%USD 1.0 bn4.9%
Hospitals22.0%21.0%USD 673 mn4.7%
Pharma and biotech24.0%26.0%USD 734 mn6.0%
Academic institutes20.0%20.0%USD 612 mn5.2%

By detection method

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Colorimetric52.0%44.0%USD 1.6 bn3.5%
Fluorescent20.0%22.0%USD 612 mn6.2%
Chemiluminescent28.0%34.0%USD 857 mn7.3%

Top 25 countries for enzyme linked immunosorbent assay by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.5% of 2026 revenue and the 25 countries below together hold 94.5%.

Exhibit 4United States is the largest country market at USD 918 mn in 2026, and the three largest countries hold 52.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Enzyme Linked Immunosorbent Assay market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 918 mn, 30.0%; China: USD 428 mn, 14.0%; Germany: USD 245 mn, 8.0%; Japan: USD 214 mn, 7.0%; France: USD 138 mn, 4.5%; United Kingdom: USD 122 mn, 4.0%; India: USD 122 mn, 4.0%; Italy: USD 107 mn, 3.5%; Brazil: USD 92 mn, 3.0%; South Korea: USD 76 mn, 2.5%.United States918 mn 30.0%China428 mn 14.0%Germany245 mn 8.0%Japan214 mn 7.0%France138 mn 4.5%United Kingdom122 mn 4.0%India122 mn 4.0%Italy107 mn 3.5%Brazil92 mn 3.0%South Korea76 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 918 mn30.0%USD 1.4 bn4.5%
2ChinaUSD 428 mn14.0%USD 843 mn7.0%
3GermanyUSD 245 mn8.0%USD 361 mn4.0%
4JapanUSD 214 mn7.0%USD 315 mn3.9%
5FranceUSD 138 mn4.5%USD 203 mn4.0%
6United KingdomUSD 122 mn4.0%USD 188 mn4.4%
7IndiaUSD 122 mn4.0%USD 290 mn9.0%
8ItalyUSD 107 mn3.5%USD 157 mn3.9%
9BrazilUSD 92 mn3.0%USD 163 mn5.9%
10South KoreaUSD 76 mn2.5%USD 132 mn5.6%
11SpainUSD 43 mn1.4%USD 67 mn4.4%
12CanadaUSD 43 mn1.4%USD 67 mn4.4%
13MexicoUSD 38 mn1.2%USD 73 mn6.8%
14AustraliaUSD 38 mn1.2%USD 59 mn4.5%
15RussiaUSD 33 mn1.1%USD 50 mn4.4%
16TurkeyUSD 33 mn1.1%USD 63 mn6.8%
17NetherlandsUSD 27 mn0.9%USD 42 mn4.5%
18SwitzerlandUSD 27 mn0.9%USD 42 mn4.5%
19PolandUSD 22 mn0.7%USD 34 mn4.4%
20TaiwanUSD 22 mn0.7%USD 34 mn4.4%
21ThailandUSD 22 mn0.7%USD 42 mn6.9%
22IranUSD 22 mn0.7%USD 34 mn4.4%
23IndonesiaUSD 22 mn0.7%USD 50 mn8.8%
24Saudi ArabiaUSD 22 mn0.7%USD 42 mn6.9%
25BelgiumUSD 16 mn0.5%USD 25 mn4.6%
Rest of worldUSD 167 mn5.5%USD 276 mn5.1%
Exhibit 5United States and China account for 46% of the USD 2.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Enzyme Linked Immunosorbent Assay market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 3.1 bn. United States: +USD 509 mn; China: +USD 415 mn; India: +USD 167 mn; Germany: +USD 116 mn; Japan: +USD 101 mn; 20 other countries: +USD 603 mn; Rest of world: +USD 109 mn. Market value 2036: USD 5.1 bn.Market value 20263.1 bnUnited States+509 mnChina+415 mnIndia+167 mnGermany+116 mnJapan+101 mn20 other countries+603 mnRest of world+109 mnMarket value 20365.1 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Roche
  • Revvity
  • Siemens Healthineers
  • Abbott
  • Danaher

Group 2: Regional and specialist players

  • Bio-Techne
  • DiaSorin
  • Merck KGaA
  • Abcam
  • Enzo Life Sciences
  • Mabtech
  • BioVendor
  • Immunodiagnostic Systems
  • RayBiotech
  • Biomerica

Group 3: Emerging and niche players

  • Elabscience
  • Creative Diagnostics
  • Boster Biological Technology
  • Assay Genie
  • Cusabio
  • Abbexa
  • MyBioSource
  • Arigo Biolaboratories

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the enzyme linked immunosorbent assay market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.2% is calculated from the resulting values.

The market is divided by product, by application, by assay format, by end user, by detection method. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the enzyme linked immunosorbent assay market?

The global enzyme linked immunosorbent assay market is estimated at USD 2.9 bn in 2025 and USD 3.1 bn in 2026.

How fast will the enzyme linked immunosorbent assay market grow?

It is forecast to reach USD 5.1 bn by 2036, a compound annual growth rate of 5.2% from 2026, an increase of USD 2.0 bn.

Which country is the largest market for enzyme linked immunosorbent assay?

United States is the largest market by revenue at USD 918 mn in 2026, 30.0% of the global total. The three largest countries together hold 52.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.0% a year from 2026 to 2036.

Which enzyme linked immunosorbent assay segment is largest?

In the by product split, Assay kits is the largest segment with 62.0% of 2026 revenue.

Who are the leading enzyme linked immunosorbent assay companies?

Global leaders include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Revvity.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Engine-Driven Endodontic File Eosinophilic Esophagitis →

All Healthcare markets →

Request a sample